Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hikma Pharmaceuticals Plc. (HKMPF)

Hikma Pharmaceuticals Plc. (HKMPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,646,293
  • Shares Outstanding, K 221,886
  • Annual Sales, $ 3,127 M
  • Annual Income, $ 359,000 K
  • EBIT $ 0 M
  • EBITDA $ 853 M
  • 60-Month Beta 0.59
  • Price/Sales 1.45
  • Price/Cash Flow 9.39
  • Price/Book 1.82
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/01/70
  • Annual Dividend & Yield 0.84 (4.01%)
  • Most Recent Dividend 0.360 on 08/15/25
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.6700 +6.46%
on 12/22/25
21.3450 -1.90%
on 12/04/25
+0.3890 (+1.89%)
since 11/20/25
3-Month
19.6700 +6.46%
on 12/22/25
25.3400 -17.36%
on 10/09/25
-0.9161 (-4.19%)
since 09/26/25
52-Week
19.6700 +6.46%
on 12/22/25
28.9150 -27.58%
on 02/24/25
-3.1800 (-13.18%)
since 12/20/24

Business Summary

Hikma Pharmaceuticals PLC develops, manufactures and markets pharmaceutical products. Its brand portfolio includes branded, injectables and generic. Branded segment offers dosage forms and strengths in the anti-infective, cardiovascular, diabetes, central nervous system, oncology and respiratory. Injectables...

See More

Key Turning Points

3rd Resistance Point 20.9400
2nd Resistance Point 20.9400
1st Resistance Point 20.9400
Last Price 20.9400
1st Support Level 20.9400
2nd Support Level 20.9400
3rd Support Level 20.9400

See More

52-Week High 28.9150
Fibonacci 61.8% 25.3834
Fibonacci 50% 24.2925
Fibonacci 38.2% 23.2016
Last Price 20.9400
52-Week Low 19.6700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar